(Total Views: 334)
Posted On: 04/23/2019 11:50:36 AM
Post# of 72440
4/9 PR
The Company is now positioning itself to further advance Brilacidin, most immediately, in its planned Phase 3 Oral Mucositis program, and in mid-stage testing for Inflammatory Bowel Disease.
Did Dr. B think a 1 and done HUGE SUCCESS meeting with EMA like some on this board did?
The Company is now positioning itself to further advance Brilacidin, most immediately, in its planned Phase 3 Oral Mucositis program, and in mid-stage testing for Inflammatory Bowel Disease.
Did Dr. B think a 1 and done HUGE SUCCESS meeting with EMA like some on this board did?
(0)
(0)Scroll down for more posts ▼
